Wednesday, July 8, 2026

biotech · Atopic Dermatitis · Moderate to Severe Atopic Dermatitis · KYMR

Kymera Therapeutics

Kymera Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

500 North Beacon Street, 4th Floor, Watertown, MA 02472, US HQ
2016 Founded
289 Employees
Public company Type
KYMR · NYSE Ticker
Company details
Status
Public
HQ
500 North Beacon Street, 4th Floor, Watertown, MA 02472, US
Founded
2016
Employees
289
Programs
12
Drugs
6
Patents
29
Intelligence · Clinical Programs

Kymera Therapeutics projects

0 ClinicalTrials.gov programs sponsored by Kymera Therapeutics.

Kymera Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Kymera Therapeutics have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.